The U.S. veterinary diagnostics market is experiencing significant growth, driven by rising pet ownership, increased spending on animal healthcare, and technological advancements in diagnostic tools. As pet owners become more invested in their animals' health and livestock producers seek better disease management solutions, the demand for reliable and efficient diagnostic services continues to surge. This article explores the current state of the market, key trends, and factors shaping its future.
The U.S. veterinary diagnostics market was valued at USD 3.39 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% through 2032. This robust growth reflects the increasing importance of diagnostic services in both companion animal and livestock sectors.
The market encompasses a wide range of diagnostic techniques and products, including hematology, immunodiagnostics, molecular diagnostics, diagnostic imaging, and clinical biochemistry. These services are utilized by veterinary hospitals, clinics, and specialized reference laboratories across the country.
One of the most significant drivers of market growth is the dramatic increase in pet ownership in the United States. According to a Forbes Advisor survey, 78% of pet owners acquired pets during the pandemic, reflecting a fundamental shift in American household dynamics. This trend has been fueled by:
Pet owners are increasingly willing to invest in preventive and diagnostic care for their animals, viewing them as valued family members rather than mere possessions. This willingness to spend on pet healthcare directly translates to higher demand for veterinary diagnostic services.
The rising incidence of veterinary disease outbreaks has created urgent demand for diagnostic solutions. For example, research published in the National Library of Medicine in 2022 revealed that approximately 7.0% of diarrheic pigs in the U.S. are infected with Porcine delta coronavirus (PDCoV). Such outbreaks underscore the critical need for rapid, accurate diagnostic tools to identify and manage animal diseases effectively.
Various government bodies, including the Food and Agriculture Organization, are actively working to increase veterinary care awareness and develop diagnostic infrastructure across the country. These initiatives create a supportive environment for market expansion and encourage investment in diagnostic capabilities.
Major players in the veterinary diagnostics sector are pursuing strategic activities such as acquisitions and partnerships to expand their product portfolios and market reach. These initiatives accelerate innovation and bring advanced diagnostic solutions to market more quickly.
One of the most transformative trends in the veterinary diagnostics market is the increasing adoption of point-of-care (POC) diagnostics. These technologies offer numerous advantages over traditional manual diagnostic methods:
Point-of-care devices are particularly valuable in veterinary settings where experienced staff may be limited. The ability to perform diagnostics on-site, rather than sending samples to reference laboratories, improves patient outcomes and client satisfaction.
A notable example of this trend is Heska Corporation's acquisition of a majority share in Biotech Laboratories U.S.A. LLC in September 2021. This strategic move allowed Heska to expand its portfolio and enter the rapid assay point-of-care diagnostics market, positioning the company for future growth.
The U.S. veterinary diagnostics market is segmented by:
This diverse segmentation reflects the varied needs of different veterinary sectors and the breadth of diagnostic applications available.
Despite strong growth prospects, the market faces certain challenges:
One of the primary restraints on market growth is the high cost associated with veterinary diagnostics. While pet owners are increasingly willing to spend on healthcare, expensive diagnostic procedures can still deter some from seeking necessary tests. This cost barrier is particularly pronounced in rural areas and among lower-income pet owners.
Addressing this challenge requires:
The U.S. veterinary diagnostics market is poised for continued expansion through 2032. Key factors supporting this growth include:
The U.S. veterinary diagnostics market represents a dynamic and growing sector within the broader healthcare industry. With a market value of USD 3.39 billion in 2023 and projected growth of 8.6% annually, the industry is well-positioned to meet the increasing diagnostic needs of both companion animal and livestock sectors. As technology advances, costs decrease, and awareness increases, veterinary diagnostics will play an increasingly central role in animal healthcare delivery across the United States.
Source: Fortune Business Insights. "U.S. Veterinary Diagnostics Market Size, Share & Industry Analysis." Retrieved from https://www.fortunebusinessinsights.com/u-s-veterinary-diagnostics-market-107887